Fluzone ( DrugBank: - )

2 diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
21	ミトコンドリア病	1
49	全身性エリテマトーデス	1

21. ミトコンドリア病

臨床試験数 : 39 / 薬物数 : 42 - (DrugBank : 32) / 標的遺伝子数 : 47 - 標的パスウェイ数 : 67

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01831934 (ClinicalTrials.gov)	September 2010	19/3/2013	Responses to Influenza Vaccine in Patients With Mitochondrial Disorders (MELAS)	Metabolic and Immune Responses to TIV in Patients With Mitochondrial Disease	MELAS Syndrome	Biological: Fluzone®	Stanford University	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)	Completed	13 Years	65 Years	All	22	Phase 4	United States

臨床試験数 : 993 / 薬物数 : 702 - (DrugBank : 184) / 標的遺伝子数 : 116 - 標的パスウェイ数 : 200

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00611611 (ClinicalTrials.gov)	October 2007	28/1/2008	BLYS and IFN in SLE	BLyS and IFN Responses to Antigen Challenge in Human SLE	Systemic Lupus Erythematosus	Biological: fluzone;Biological: pneumovax	University of Alabama at Birmingham	Hospital for Special Surgery, New York	Completed	19 Years	65 Years	Both	39	N/A	United States